Skinvisible (SKVI) Share-based Compensation (QoQ) (2010 - 2017)
Powered by 
Analysis
Skinvisible (SKVI) Share-based Compensation (QoQ) (2010 - 2017) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.06 Bn | 626.30 Bn | 17.26 Bn |
| 2 | AbbVie | 440.06 Bn | 433.49 Bn | 12.70 Bn |
| 3 | Merck | 364.19 Bn | 357.05 Bn | 12.21 Bn |
| 4 | Novartis Ag | 268.45 Bn | 260.76 Bn | 11.24 Bn |
| 5 | Pfizer | 158.40 Bn | 146.70 Bn | 10.94 Bn |
| 6 | Sanofi | 52.57 Bn | 45.19 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.32 Bn | 44.32 Bn | - |
| 8 | Incyte | 24.98 Bn | 20.44 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.15 Bn | 18.49 Bn | 683.80 Mn |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | 27.81% |
| Sep 30, 2017 | -48.21% |
| Jun 30, 2017 | 280.55% |
| Mar 31, 2017 | 95.11% |
| Mar 31, 2016 | 2,568.90% |
| Mar 31, 2015 | -62.39% |
| Dec 31, 2014 | -11.53% |
| Sep 30, 2013 | 180.00% |
| Jun 30, 2013 | -69.39% |
| Mar 31, 2013 | -74.88% |
| Dec 31, 2011 | -34.95% |
| Sep 30, 2011 | 68.85% |
| Jun 30, 2011 | -78.67% |
| Mar 31, 2011 | 138.64% |
| Dec 31, 2010 | 21.41% |